This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 3 for:    NORDSTEN

The NORDSTEN Studies/ The Spinal Stenosis Study (NORDSTEN/SST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02007083
Recruitment Status : Active, not recruiting
First Posted : December 10, 2013
Last Update Posted : August 12, 2020
Sponsor:
Collaborator:
Møre og Romsdal Hospital Trust
Information provided by (Responsible Party):
Haukeland University Hospital

Brief Summary:
Lumbar Spinal Stenosis (LSS) is a clinical entity were narrowing of the spinal canal gives a compression of the the neural and vascular structures in the spinal canal. This often gives neurogenic claudication and sometimes severe Low Back Pain (LBP). Surgery for LSS is today the most often performed procedure in the adult lumbar spine. Beneficial effect of surgical treatment is well documented by several clinical trials, and a Cochrane review article from 2005 concludes that surgical treatment is superior to non-surgical treatment. The surgical solution is to decompress the stenotic part of the lumbar spine. There is no consensus in the literature of which surgical method that gives best long term clinical results. The investigators are therefore planning a Randomized Controlled Trial, where they will compare clinical and radiological results of three different surgical methods for LSS. The main outcome of this study is to answer which surgical method that gives the best long term clinical results. And, secondary outcome is to find out how much increase of the Dural Sac Cross Sectional Area is needed to give a long time relief of the patients' symptoms.

Condition or disease Intervention/treatment Phase
Lumbar Spinal Stenosis Procedure: Bilateral laminotomy (BL) Procedure: Unilateral laminotomy with crossover (UL) Procedure: Spinous Process Osteotomy (SPO) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 465 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Comparison of Different Surgical Treatments for Lumbar Spinal Stenosis. A Randomized Controlled Trial Comparing the Clinical and Radiological Results Using "Spinous Process Osteotomy", "Bilateral Laminotomy" and "Unilateral Laminotomy With Crossover"
Actual Study Start Date : November 2013
Estimated Primary Completion Date : October 2028
Estimated Study Completion Date : December 2028

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Spinal Stenosis

Arm Intervention/treatment
Active Comparator: Bilateral laminotomy (BL)
The multifidus muscles is detached from the spinous process bilaterally.The decompression of the spinal canal is performed by first doing a flavectomy. Thereby performing a laminotomy (about 1/3) of the the lower part of the superior lamina, and a laminotomy of the upper part (about 1/4) of the inferior lamina. This is performed bilaterally.
Procedure: Bilateral laminotomy (BL)
Other Names:
  • Fenestration procedures.
  • Multiple laminotomies.

Active Comparator: Unilateral laminotomy with crossover (UL)
The multifidus muscles is detached from the spinous process unilaterally. The laminotomy is first performed ipsilaterally. The decompression of the spinal canal is performed by first doing a flavectomy. Then, performing a laminotomy (about 1/3) of the the lower part of the superior lamina, and a laminotomy of the upper part (about 1/4) of the inferior lamina. Dura is then retracted, and the decompression is performed contralaterally.
Procedure: Unilateral laminotomy with crossover (UL)
Other Name: microdecompression.

Active Comparator: Spinous process osteotomy (SPO)
The multifidus muscles is detached from the spinous process unilaterally. An osteotomy of the superior spinous process is performed at the basis, in the actual level. The spinous process with intact interspinal and supraspinal ligaments is then retracted to the contralateral side. The decompression is first performed in the midline. Then one goes laterally on both sides too perform the decompression. About 1/3 of the lower part of the superior lamina is removed, and about 1/4 of the upper part of the inferior lamina is removed.
Procedure: Spinous Process Osteotomy (SPO)
Other Names:
  • Laminarthrectomi.
  • Micro Spinous Process Osteotomy




Primary Outcome Measures :
  1. Oswestry Disability Index [ Time Frame: 2, 5 and 10 years after surgery ]

    The investigators will monitor the ODI-index before and after surgery, and calculate the change of ODI after surgery compared to baseline.

    The primary outcome is a measurement of the change of ODI (version 2.0) from baseline in the three different surgical groups. This will be done by calculating the mean ODI improvement in each group. The investigators will also compare the proportion of "success patients" between the SPO group, the BL group and the UL group, 24 months after the operation. The investigators will dichotomize the patients, in a "succesful outcome group" and in a "non- succesful outcome group". The threshold value for being categorized as a "succesful outcome" will be computed in a planned study based on data from The Norwegian Registry for Spine Surgery (NORSpine).

    The investigators also plan to asses short time results after 2 years, intermediate results after 5 years, and long time results after 10 years.



Secondary Outcome Measures :
  1. Zurich claudification Scale, Numeric Rating Scale for leg pain, Numeric Rating Scale for back pain, EQ-5D, and self evaluated effect of surgery. [ Time Frame: 2, 5 and 10 years after surgery ]

    All of the above mentioned questionaires are validated and reliable questionaires to asses the effect of surgical treatment. The effect of the surgical treatment is calculated by the improvement of the different scores, and thereby is an objective way to asses the effect of the surgical treatment.

    The investigators plan to asses short time results after 2 years, intermediate results after 5 years, and long time results after 10 years.



Other Outcome Measures:
  1. Dural Sac Cross sectional Area (DSCSA) [ Time Frame: 3 months after surgery ]
    The investigators are planning to investigate the DSCSA before and after surgery. Thereby we can monitor which surgical procedure that increases the DSCSA the most. The investigators will also investigate wether a large increase of the DSCSA is needed to maintain good long-time clinical results.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • have clinical symptoms of spinal stenosis as neurogenic claudication or radiating pain into the bilaterally to the lower limbs, not responding to at least 3 months of conservative treatment.
  • Radiological findings corresponding to the clinical symptoms of LSS. Central -stenosis, or lateral recess-stenosis.
  • be able to give informed consent and to answer the questionnaires.
  • over 18 years of age-have -not responding to at least 3 months of non-surgical treatment.
  • be able to understand Norwegian language, spoken and in writing

Exclusion Criteria:

  • have a degenerative lumbar spondylolisthesis, with a slip ≥ 3 mm verified on standing plain x-rays in lateral view.
  • are not willing to give written consent.
  • have former surgery in the level of stenosis.
  • fracture, or former fusion of the thoracolumbal region.
  • cauda equina syndrome (bowel or bladder dysfunction) or fixed complete motor deficit.
  • are ASA- classified 4 or 5.
  • are older than 80 years
  • have a lumbosacral scoliosis more than 20 degrees verified on AP-view
  • have distinct symptoms in one or both of their legs due to other diseases, e.g. polyneuropaty, vascular claudication or osteoarthtris.
  • LSS in 4 or more levels.
  • not able to comply fully with the protocol, including treatment, follow-up or study procedures (psychosocially, mentally and physical).
  • the patient is participating in another clinical trial that may interfere with this trial

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02007083


Locations
Layout table for location information
Norway
Haukeland University Hospital
Bergen, Hagevik, Norway, 5217
Sponsors and Collaborators
Haukeland University Hospital
Møre og Romsdal Hospital Trust
Investigators
Layout table for investigator information
Study Director: Kari Indrekvam Indrekvam, MD, Dr Med The Coastal Hospital of Hagevik, Orthopeadic Clinic, Haukeland University City
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Haukeland University Hospital
ClinicalTrials.gov Identifier: NCT02007083    
Other Study ID Numbers: 2011/2034
2011/2034
First Posted: December 10, 2013    Key Record Dates
Last Update Posted: August 12, 2020
Last Verified: August 2020
Keywords provided by Haukeland University Hospital:
Lumbar Spinal stenosis
Surgical treatment of LSS.
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Stenosis
Constriction, Pathologic
Pathological Conditions, Anatomical
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases